JP2003511415A5 - - Google Patents

Download PDF

Info

Publication number
JP2003511415A5
JP2003511415A5 JP2001529444A JP2001529444A JP2003511415A5 JP 2003511415 A5 JP2003511415 A5 JP 2003511415A5 JP 2001529444 A JP2001529444 A JP 2001529444A JP 2001529444 A JP2001529444 A JP 2001529444A JP 2003511415 A5 JP2003511415 A5 JP 2003511415A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
naphthyl
substituents
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001529444A
Other languages
English (en)
Japanese (ja)
Other versions
JP4961084B2 (ja
JP2003511415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/027591 external-priority patent/WO2001026654A1/en
Publication of JP2003511415A publication Critical patent/JP2003511415A/ja
Publication of JP2003511415A5 publication Critical patent/JP2003511415A5/ja
Application granted granted Critical
Publication of JP4961084B2 publication Critical patent/JP4961084B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001529444A 1999-10-08 2000-10-06 Fabi阻害剤 Expired - Fee Related JP4961084B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15852999P 1999-10-08 1999-10-08
US60/158,529 1999-10-08
PCT/US2000/027591 WO2001026654A1 (en) 1999-10-08 2000-10-06 Fab i inhibitors

Publications (3)

Publication Number Publication Date
JP2003511415A JP2003511415A (ja) 2003-03-25
JP2003511415A5 true JP2003511415A5 (enExample) 2012-03-22
JP4961084B2 JP4961084B2 (ja) 2012-06-27

Family

ID=22568552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001529444A Expired - Fee Related JP4961084B2 (ja) 1999-10-08 2000-10-06 Fabi阻害剤

Country Status (8)

Country Link
EP (1) EP1225895B1 (enExample)
JP (1) JP4961084B2 (enExample)
AT (1) ATE294578T1 (enExample)
AU (1) AU1192501A (enExample)
CO (1) CO5251401A1 (enExample)
DE (1) DE60019954T2 (enExample)
HK (1) HK1049610A1 (enExample)
WO (1) WO2001026654A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
DE60029235T2 (de) * 1999-10-08 2007-06-14 Affinium Pharmaceuticals, Inc., Toronto Fab-i-hemmer
ECSP003699A (es) 1999-10-08 2002-04-23 Smithkline Beecham Corp Inhibidores de fab i
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
MXPA03003039A (es) * 2000-10-06 2003-10-15 Neurogen Corp Derivados de indola y bencimidazola como moduladores del receptor crf.
DE60230934D1 (de) 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
EP1575951B1 (en) * 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
CN101203504B (zh) * 2005-05-03 2012-11-14 兰贝克赛实验室有限公司 抗微生物剂
US8076370B2 (en) 2005-05-03 2011-12-13 Ranbaxy Laboratories Limited Antimicrobial agents
JP2009533315A (ja) * 2006-04-10 2009-09-17 ランバクシー ラボラトリーズ リミテッド 抗菌剤
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
CN104039782A (zh) 2011-08-10 2014-09-10 爱尔兰詹森研发公司 抗菌的高哌啶基取代的3,4二氢1h[1,8]萘啶酮类
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
BR112014002958B1 (pt) 2011-08-10 2020-10-06 Janssen Sciences Ireland Uc 3,4-dihidro-1h-[1,8]naftiridinonas substituídas com piperidinila antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
JP6250668B2 (ja) 2012-08-10 2017-12-20 ヤンセン・サイエンシズ・アイルランド・ユーシー 新しい抗菌化合物
EA201590339A1 (ru) 2012-08-10 2015-06-30 Янссен Сайенсиз Айрлэнд Юси Новые антибактериальные соединения
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
MY203711A (en) 2019-02-14 2024-07-15 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
JP7418475B2 (ja) 2019-06-14 2024-01-19 デバイオファーム インターナショナル エス.エー. バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) * 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds

Similar Documents

Publication Publication Date Title
JP2003511415A5 (enExample)
RU2328485C2 (ru) Производные индолинфенилсульфамида
YU47437B (sh) Novi derivati izoindolona i njihovo dobivanje
NO20015447D0 (no) Kinolinderivater som inhibitorer av MEK enzymer
RU93046499A (ru) Способ увеличения относительной плотности полиамидов
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
EP1826196A3 (en) Vinyl ether compounds
RU98123954A (ru) Алкилзамещенные циклические амины в качестве селективных лигандов d3-допамина
DE60239170D1 (de) Bicyclische Verbindungen
YU47219B (sh) Antivirusna tetrahidroimidazo (1,4) benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje
EA199801013A1 (ru) Производные дистамицина, способ их получения и применение в качестве противоопухолевых и противовирусных агентов
SE8503466L (sv) Aminofenolforeningar
ES405942A1 (es) Procedimiento para la preparacion de 2-fenilimino-imidazo- lidinas.
ATE152720T1 (de) Zyklische (hetero)acetale nitrosubstituierter benzaldehyde mit wirkung gegen krebs
JP2003504349A5 (enExample)
SE7706655L (sv) Nya bensylcyanoacetaler och sett att framstella dessa
ATE368035T1 (de) Herstellung von phthalanen
BG97173A (bg) Циклични производни на аминофенилоцетната киселина,метод за получаването им и приложението им
DK145286D0 (da) Bicyclooctanderivater
IE780096L (en) Quinoxalines
WO2000008020A3 (en) Tricyclic carboxamides
JPH1060307A5 (enExample)
SE8401190D0 (sv) Bensamidderivat
KR970706280A (ko) 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)
FI922981A0 (fi) 2-aminopyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa.